Updated on 2 January 2015
Elanco, Eli Lilly's animal health company, aims to expand its global business
Singapore: Eli Lilly has acquired animal health division of Novartis at $5.4 billion with the strategy to strengtehn its portfolio in animal health industry.
Elanco, Eli Lilly's animal health company, aims to expand its global business with the acquisition.
"As a top-tier animal health company, we are better positioned to help our customers respond to the changing external environment and meet increasing demands for animal protein, as well as growing desires for pet ownership," said Mr Jeff Simmons, senior vice president, Eli Lilly.